Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Absorption Test

Research Leaders

16 sponsors active, led by World Health Organization

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (2)
Phase 2 (1)
Phase 3 (2)

Trial Status

Unknown2
Not Yet Recruiting1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Absorption Test1
  • Sodium Chloride 09 Placebo1
  • Dexametasone1
  • Xiyanping Injectionoseltamivir Phosphate1
  • Oseltamivir Phosphate1

Active Sponsors

  • World Health Organization1
  • Qingdao Municipal Hospital1
  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine1
  • Centre Hospitalier Régional Metz-Thionville1

Top Investigators

Related Conditions

  • Patients With Influenzainduced Acute Hypoxemic Respiratory Failure1
  • Adult Patients Admitted To The Icu For Management Of Severe Influenza Infection Requiring Orotracheal Intubation For Invasive Mechanical Ventilation1
  • Hygiene1
  • Intensive Care Icu1
  • Avian Influenza1

Activity Timeline